Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia

Name: Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
Published: 2026
License: Public Domain

Quetzal Therapeutics · 2026

ClinicalTrials.gov · Datasets · License: Public Domain · 2026

Open Source ↗

drug-therapy hematology leukemia oncology therapeutics

acute promyelocytic leukemia (apl), acute promyelocytic leukaemia, acute promyelocytic leukemia with pml-rara, acute promyelocytic leukemia with t(15;17)(q24.1;q21.2); pml-rara, acute promyelocytic leukemia, apl, hematology, oncology, leukemia, hematologic disease, drug therapy, therapeutics

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 844983
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.